December 18, 2019 The government’s current review of the proposed merger between defense contractor Raytheon and United Technologies (UT) may not...
July 26, 2019 (Arlington, Virginia) — This morning CASE Chairman Gerard Scimeca issued a statement praising the Department of Justice’s...
Gerard Scimeca – Chairman, CASE June 24, 2019 In a decision that surprised the many, on Thursday the Department of...
Gerard Scimeca – Chairman, CASE April 22, 2019 The Wall Street Journal offers some very sobering news for U.S....
Below is the letter sent from CASE President Matthew Kandrach to members and staff of the U.S. Senate Judiciary Committee,...
Gerard Scimeca, CASE Chairman December 11, 2017 – http://bit.ly/2AbxGBC With the recent $69 billion acquisition of Aetna insurance by CVS —...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
